Data shows mRNA-1010 could better protect adults aged 50 and above
Category: News
Positive trial results offer hope for those with ultra-rare epileptic disorder
New data show strong efficacy of CD388 in phase 2b trial
Introduction This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. […]
PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise collaborations that deliver […]
Enter this year’s famous competition
The pilot will see GP practices look at patient records to identify those most at risk
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US